The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
High-dimensional propensity score adjustment in studies of treatment effects using health care claims data.
Open accessAbstract
BACKGROUND: Adjusting for large numbers of covariates ascertained from patients' health care claims data may improve control of confounding, as these variables may collectively be proxies for unobserved factors. Here, we develop and test an algorithm that empirically identifies candidate covariates, prioritizes covariates, and integrates them into a propensity-score-based confounder adjustment model. METHODS: We developed a multistep algorithm to implement high-dimensional proxy adjustment in claims data. Steps include (1) identifying data dimensions, eg, diagnoses, procedures, and medications; (2) empirically identifying candidate covariates; (3) assessing recurrence of codes; (4) prioritizing covariates; (5) selecting covariates for adjustment; (6) estimating the exposure propensity score; and (7) estimating an outcome model. This algorithm was tested in Medicare claims data, including a study on the effect of Cox-2 inhibitors on reduced gastric toxicity compared with nonselective nonsteroidal anti-inflammatory drugs (NSAIDs). RESULTS: In a population of 49,653 new users of Cox-2 inhibitors or nonselective NSAIDs, a crude relative risk (RR) for upper GI toxicity (RR = 1.09 [95% confidence interval = 0.91-1.30]) was initially observed. Adjusting for 15 predefined covariates resulted in a possible gastroprotective effect (0.94 [0.78-1.12]). A gastroprotective effect became stronger when adjusting for an additional 500 algorithm-derived covariates (0.88 [0.73-1.06]). Results of a study on the effect of statin on reduced mortality were similar. Using the algorithm adjustment confirmed a null finding between influenza vaccination and hip fracture (1.02 [0.85-1.21]). CONCLUSIONS: In typical pharmacoepidemiologic studies, the proposed high-dimensional propensity score resulted in improved effect estimates compared with adjustment limited to predefined covariates, when benchmarked against results expected from randomized trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This algorithm leverages that large volumes of covariates can collectively serve as good proxies for unmeasured confounders and thus produce results from observational data that more closely resemble results from randomization.42”
From Hysterectomy versus uterine preservation for pelvic organ prolapse surgery: a prospective cohort study (2025) · cites this paper as [42]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2001) · RePEc: Research Papers in Economics · Cited by 27,577
Revisiting the Behavioral Model and Access to Medical Care: Does it Matter?
Andersen, R. M. (1995) · Journal of Health and Social Behavior · doi:10.2307/2137284 · Cited by 9,831
Variable Selection for Propensity Score Models
Brookhart, M. A., Schneeweiss, S., Rothman, K. J., Glynn, R. J., Avorn, J., & Stürmer, T. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj149 · Cited by 2,336
Self-citationEvaluating medication effects outside of clinical trials: new-user designs
Ray, W. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg231 · Cited by 1,646
A review of uses of health care utilization databases for epidemiologic research on therapeutics
Schneeweiß, S., & Avorn, J. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.10.012 · Cited by 1,290
Self-citationHirano, K., & Imbens, G. W. (2001) · Health Services and Outcomes Research Methodology · doi:10.1023/a:1020371312283 · Cited by 1,039
Unified Methods for Censored Longitudinal Data and Causality
van der Laan, M. J., & Robins, J. M. (2003) · Springer series in statistics · doi:10.1007/978-0-387-21700-0 · Cited by 979
Quantifying Biases in Causal Models: Classical Confounding vs Collider-Stratification Bias
Greenland, S. (2003) · Epidemiology · doi:10.1097/01.ede.0000042804.12056.6c · Cited by 810
Stürmer, T., Joshi, M., Glynn, R. J., Avorn, J., Rothman, K. J., & Schneeweiß, S. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.07.004 · Cited by 668
Self-citationSolomon, D. H., Schneeweiß, S., Glynn, R. J., Kiyota, Y., Levin, R., Mogun, H., & Avorn, J. (2004) · Circulation · doi:10.1161/01.cir.0000127578.21885.3e · Cited by 506
Self-citation
Flagged first, then by citations
1 of the 44 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Arana, 2004, What do we show and who does so? An analysis of the abstracts presented at the 19th ICPE., Pharmacoepidemiol Drug Saf, 13, S330
Cited by
Sorted by citations
Items 501–600 of 1,000
Burne, R. M., & Abrahamowicz, M. (2017) · Statistical Methods in Medical Research · doi:10.1177/0962280217726800 · Cited by 19
Blin, P., Dureau‐Pournin, C., Cottin, Y., Bénichou, J., Mismetti, P., Abouelfath, A., Lassalle, R., Droz‐Perroteau, C., & Moore, N. D. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1318 · Cited by 19
Rea, F., Ieva, F., Pastorino, U., Apolone, G., Barni, S., Merlino, L. G., Franchi, M., & Corrao, G. (2020) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezaa031 · Cited by 19
Benzodiazepine use before conception and risk of ectopic pregnancy
Wall‐Wieler, E., Robakis, T. K., Lyell, D. J., Masarwa, R., Platt, R. W., & Carmichael, S. L. (2020) · Human Reproduction · doi:10.1093/humrep/deaa082 · Cited by 19
Wang, M., Huang, Y., Lai, J., Lee, C., Wang, P.-C., Pan, H.-Y., Lin, C., Liou, J., & Hsu, Y. (2022) · Diabetes Care · doi:10.2337/dc21-1779 · Cited by 19
Secrest, M. H., Platt, R. W., Dormuth, C. R., Chateau, D. G., Targownik, L. E., Nie, R., Doyle, C. M., Dell’Aniello, S., & Filion, K. B. (2019) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4708 · Cited by 19
Brennand, E. A., Scime, N. V., Huang, B., Edwards, A. D., Kim-Fine, S., Hall, J., Birch, C., Robert, M., & Carter Ramirez, A. (2025) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2024.10.021 · Cited by 18
Integrating Artificial Intelligence into Causal Research in Epidemiology
Matthay, E. C., Neill, D. B., Titus, A. R., Desai, S. M., Troxel, A. B., Cerdá, M., Diaz, I. M., Santacatterina, M., & Thorpe, L. E. (2025) · Current Epidemiology Reports · doi:10.1007/s40471-025-00359-5 · Cited by 18
Signal detection for vaccine side effects that have not been specified in advance
Walker, A. M. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1889 · Cited by 18
Zhang, J., Yun, H., Wright, N. C., Kilgore, M. L., Saag, K. G., & Delzell, E. (2011) · Current Rheumatology Reports · doi:10.1007/s11926-011-0168-8 · Cited by 18
Courtois, É., Pariente, A., Salvo, F., Volatier, É., Tubert‐Bitter, P., & Ahmed, I. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01010 · Cited by 20
Is there an association between liraglutide use and female breast cancer in a real-world setting?
Funch, D. P., Mortimer, K., Li, L., Norman, H. S., Major‐Pedersen, A., Olsen, A. H., Kaltoft, M. S., & Dore, D. D. (2018) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s171503 · Cited by 18
Blin, P., Dureau‐Pournin, C., Cottin, Y., Bénichou, J., Mismetti, P., Abouelfath, A., Lassalle, R., Droz‐Perroteau, C., & Moore, N. D. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13815 · Cited by 18
Rossides, M., Kullberg, S., Askling, J., Eklúnd, A., Grünewald, J., Giuseppe, D. D., & Arkema, E. V. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00611-w · Cited by 18
Statins and lower mortality in rheumatic diseases: An effect of immortal time bias?
Abrahami, D., Hudson, M., & Suissa, S. (2020) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2020.11.010 · Cited by 18
Health Outcomes in Young Children Following Pertussis Vaccination During Pregnancy
Laverty, M., Crowcroft, N. S., Bolotin, S., Hawken, S., Wilson, K. R., Amirthalingam, G., Biringer, A. B., Cook, J. L., Dubey, V., Fakhraei, R., et al. (2021) · PEDIATRICS · doi:10.1542/peds.2020-042507 · Cited by 18
Polinski, J. M., Schneeweiß, S., Glynn, R. J., Lii, J., & Rassen, J. A. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3250 · Cited by 18
Self-citationNon-parametric causality detection: An application to social media and financial data
Tsapeli, F., Musolesi, M., & Peter Tiňo, B. (2017) · Physica A Statistical Mechanics and its Applications · doi:10.1016/j.physa.2017.04.101 · Cited by 19
Polypharmacy and risk of fractures in older adults: A systematic review
Gagnon, M.-È., Talbot, D. C., Tremblay, F., Desforges, K., & Sirois, C. (2024) · Journal of Evidence-Based Medicine · doi:10.1111/jebm.12593 · Cited by 17
McCandless, L. C. (2013) · Epidemiology · doi:10.1097/ede.0b013e31829eef0a · Cited by 17
Lee, Y., Chang, C., Dong, Y., Lin, J., Wu, L., Hwang, J., & Chuang, L. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.11.022 · Cited by 17
Cadarette, S. M., Ban, J. K., Consiglio, G. P., Black, C. D., Dubins, D. N., Marin, A., & Tadrous, M. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2016.12.006 · Cited by 17
Huybrechts, K. F., Gopalakrishnan, C., Franklin, J. M., Zint, K., França, L. R., Bartels, D. B., Landon, J. E., & Schneeweiß, S. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1256 · Cited by 17
Liraglutide use and evaluation of pancreatic outcomes in a US commercially insured population
Funch, D., Mortimer, K. M., Ziyadeh, N., Seeger, J., Li, L., Norman, H., Major-Pedersen, A., Bosch-Traberg, H., Gydesen, H., & Dore, D. (2019) · Diabetes, obesity and metabolism · doi:10.1111/dom.13739 · Cited by 16
Chien, S., Ou, S., Shih, C.-J., Chao, P.-W., Li, S., Lee, Y.-J., Kuo, S., Wang, S., Chen, T., Tarng, D., et al. (2015) · Medicine · doi:10.1097/md.0000000000001751 · Cited by 17
Effect of glycemic control on the risk of pancreatic cancer
Er, K.-C., Hsu, C.-Y., Lee, Y., Huang, M.-Y., & Su, Y. (2016) · Medicine · doi:10.1097/md.0000000000003921 · Cited by 17
Estimating average treatment effects with a double‐index propensity score
Cheng, D. T.-Y., Chakrabortty, A., Ananthakrishnan, A. N., & Cai, T. (2019) · Biometrics · doi:10.1111/biom.13195 · Cited by 17
Health Maintenance Organizations/Health Plans
Andrade, S. E., Raebel, M. A., Boudreau, D. M., Davis, R. L., Haffenreffer, K., Pawloski, P. A., Toh, S., & Platt, R. G. (2012) · Pharmacoepidemiology · doi:10.1002/9781119959946.ch12 · Cited by 17
Gillespie, I. A., Floege, J., Gioni, I., Drüeke, T. B., de Francisco, A. L. M., Anker, S. D., Kubo, Y., Wheeler, D. C., & Froissart, M. (2015) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3789 · Cited by 17
Wyss, R., FIREMAN, B. H., Rassen, J. A., & Schneeweiß, S. (2018) · Epidemiology · doi:10.1097/ede.0000000000000886 · Cited by 17
Self-citationKajiyama, H., Suzuki, S., Yoshikawa, N., Tamauchi, S., Shibata, K., & Kikkawa, F. (2020) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2020.31.e47 · Cited by 16
New adaptive lasso approaches for variable selection in automated pharmacovigilance signal detection
Courtois, É., Tubert‐Bitter, P., & Ahmed, I. (2021) · BMC Medical Research Methodology · doi:10.1186/s12874-021-01450-3 · Cited by 17
Wyss, R., van der Laan, M. J., Gruber, S., Shi, X., Lee, H., Dutcher, S. K., Nelson, J. C., Toh, S., Russo, M., Wang, S. V., et al. (2024) · American Journal of Epidemiology · doi:10.1093/aje/kwae023 · Cited by 16
Schuemie, M. J., Ryan, P. B., Suchard, M. A., Shahn, Z., & Madigan, D. (2013) · Biostatistics · doi:10.1093/biostatistics/kxt037 · Cited by 16
Nam, Y. H., Brensinger, C. M., Bilker, W. B., Leonard, C. E., Kasner, S. E., Großer, T., Li, X., & Hennessy, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193800 · Cited by 16
Schmedt, N., Enders, D., Walker, J., Garbe, E., & Douros, A. (2020) · The American Journal of Medicine · doi:10.1016/j.amjmed.2020.10.046 · Cited by 16
Go, A. S., Leong, T. K., Sung, S. H., Wei, R. X., Harrison, T. N., Gupta, N., Baker, N., Goldstein, B., Ataher, Q., Solomon, M. D., et al. (2022) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-022-02695-5 · Cited by 16
Wang, J., Gagne, J. J., Sreedhara, S. K., Fischer, M. A., & Bykov, K. (2022) · BMJ · doi:10.1136/bmj-2021-069931 · Cited by 16
Li, L., Vollmer, W. M., Butler, M. G., Wu, P., Kharbanda, E. O., & Wu, A. C. (2014) · American Journal of Epidemiology · doi:10.1093/aje/kwt323 · Cited by 16
Hu, L., Mitchell, L., Zhang, X., Heiselman, D., & Motsko, S. P. (2017) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2017.09.010 · Cited by 16
Mahmud, S. M., Bozat‐Emre, S., Mostaço-Guidolin, L. C., & Marrie, R. A. (2018) · Emerging infectious diseases · doi:10.3201/eid2407.161783 · Cited by 16
Huybrechts, K. F., Gopalakrishnan, C., Bartels, D. B., Zint, K., Gurusamy, V. K., Landon, J. E., & Schneeweiß, S. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1753 · Cited by 15
Karter, A. J., Parker, M. M., Moffet, H. H., Gilliam, L. K., & Dlott, R. S. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0450 · Cited by 15
Incorporating causal modeling into data envelopment analysis for performance evaluation
Fukuyama, H., Tsionas, E. G., & Tan, Y. (2023) · Annals of Operations Research · doi:10.1007/s10479-023-05486-0 · Cited by 15
Lawal, O. D., Aronow, H. D., Hume, A. L., Shobayo, F. O., Matson, K. L., Barbour, M. M., Zhang, Y., & Wen, X. (2023) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2023.102293 · Cited by 17
Shah, B. R., Hwee, J., Cauch‐Dudek, K., Ng, R., & Victor, J. C. (2015) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.12360 · Cited by 15
Spertus, J. V., & Normand, S. T. (2018) · Biometrical Journal · doi:10.1002/bimj.201700305 · Cited by 17
Analytical Methods for a Learning Health System: 3. Analysis of Observational Studies
Stoto, . A., Oakes, M., Stuart, E. A., Brown, R., Zurovac, J., & Priest, E. L. (2017) · eGEMs (Generating Evidence & Methods to improve patient outcomes) · doi:10.5334/egems.252 · Cited by 15
Lutsey, P. L., Norby, F. L., Zakai, N. A., MacLehose, R. F., Chen, L. Y., Shah, S., Datta, Y. H., & Alonso, Á. (2018) · Current Medical Research and Opinion · doi:10.1080/03007995.2018.1541445 · Cited by 15
Comparison of cholinesterase inhibitor safety in real‐world practice
Carney, G., Bassett, K. L., Wright, J. M., Maclure, M., McGuire, N., & Dormuth, C. R. (2019) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2019.09.011 · Cited by 15
Is Switching from Oral Antidiabetic Therapy to Insulin Associated with an Increased Fracture Risk?
Corrao, G., Compagnoni, M. M., Ronco, R., Merlino, L. G., Ciardullo, S., Perseghin, G., & Banfi, G. (2019) · Clinical Orthopaedics and Related Research · doi:10.1097/corr.0000000000001089 · Cited by 15
Shu, D., Han, P., Wang, R., & Toh, S. (2021) · Statistics in Medicine · doi:10.1002/sim.8837 · Cited by 15
Pressat-Laffouilhère, T., Jouffroy, R., Guillou, A. L., Kerdelhué, G., Bénichou, J., & Gillibert, A. (2021) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2021.07.006 · Cited by 15
Serotonin-Norepinephrine Reuptake Inhibitors and the Risk of AKI
Renoux, C., Lix, L. M., Patenaude, V., Bresee, L. C., Paterson, J. M., Lafrance, J., Tamim, H., Mahmud, S. M., Alsabbagh, M. W., Hemmelgarn, B. R., et al. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11271114 · Cited by 15
Larivée, N., Suissa, S., Coulombe, J., Tagalakis, V., & Filion, K. B. (2017) · Drug Safety · doi:10.1007/s40264-017-0525-2 · Cited by 15
Translational medicine in the Age of Big Data
Tatonetti, N. P. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbx116 · Cited by 15
Rose, S., & Normand, S. T. (2018) · Biometrics · doi:10.1111/biom.12927 · Cited by 15
Carney, G., Bassett, K. L., Maclure, M., Taylor, S., & Dormuth, C. R. (2020) · Addiction · doi:10.1111/add.14951 · Cited by 15
Alkabbani, W., Zongo, A., Minhas‐Sandhu, J. K., Eurich, D. T., Shah, B. R., Alsabbagh, M. W., & Gamble, J. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002496 · Cited by 16
Moore, N. D., Blin, P., & Droz‐Perroteau, C. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_318 · Cited by 15
Gupta, N., Yang, J., Reynolds, K., Lenane, J., Garcia, E., Sung, S. H., Harrison, T. N., Solomon, M. D., & Go, A. S. (2022) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2021.11.027 · Cited by 14
Leonard, S. A., Siadat, S., Huybrechts, K. F., Main, E. K., Hlatky, M. A., Hernández–Dı́az, S., & Bateman, B. T. (2025) · JACC Advances · doi:10.1016/j.jacadv.2025.102054 · Cited by 15
Insulin Use in Type 2 Diabetes and the Risk of Dementia: A Comparative Population-Based Cohort Study
Alkabbani, W., Maxwell, C. J., Marrie, R. A., Tyas, S. L., Lega, I. C., & Gamble, J. (2023) · Diabetes Care · doi:10.2337/dc23-0222 · Cited by 14
Karim, M. E. (2024) · The American Statistician · doi:10.1080/00031305.2024.2368794 · Cited by 14
Risk of Pneumonia in New Users of Cholinesterase Inhibitors for Dementia
Lai, E. C., Wong, M. B., Iwata, I., Zhang, Y., Hsieh, C., Yang, Y. K., & Setoguchi, S. (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13380 · Cited by 14
Pedersen, L. H., Petronis, K. R., Nørgaard, M., Mo, J., Frøslev, T., Stephansson, O., Granath, F. N., Kieler, H., & Sørensen, H. T. (2019) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4894 · Cited by 15
Alzheimer's disease medication and outcomes of hospitalisation among patients with dementia
Möllers, T., Perna, L., Stocker, H. R., Ihle, P., Schübert, I., Schöttker, B., Frölich, L., Bauer, J. M., & Brenner, H. (2019) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796019000702 · Cited by 15
Brown, D. W., DeSantis, S., Greene, T. J., Maroufy, V., Yaseen, A., Wu, H.-L., Williams, G., & Swartz, M. (2020) · Statistics in Medicine · doi:10.1002/sim.8540 · Cited by 15
Dhopeshwarkar, N., Brensinger, C. M., Bilker, W. B., Soprano, S. E., Flory, J., Dawwas, G. K., Gagne, J. J., Hennessy, S., & Leonard, C. E. (2020) · Scientific Reports · doi:10.1038/s41598-020-66668-5 · Cited by 14
Parikh, R., Nash, D. M., Brimble, K. S., Markle‐Reid, M., Tan, T. C., McArthur, E., Khoshniat-Rad, F., Sood, M. M., Zheng, S., Pravoverov, L. V., et al. (2020) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.119.006415 · Cited by 14
Prats‐Uribe, A., Kolovos, S., Berencsi, K., Carr, A. J., Judge, A., Silman, A. J., Arden, N., Petersen, I., Douglas, I., Wilkinson, J. M., et al. (2021) · Health Technology Assessment · doi:10.3310/hta25660 · Cited by 14
Hossain, M. B., Johnston, J. C., Cook, V. J., Sadatsafavi, M., Wong, H., Romanowski, K., & Karim, M. E. (2023) · Epidemiology and Infection · doi:10.1017/s0950268823000559 · Cited by 14
Rebar: Reinforcing a Matching Estimator With Predictions From High-Dimensional Covariates
Sales, A., Hansen, B. B., & Rowan, B. (2017) · Journal of Educational and Behavioral Statistics · doi:10.3102/1076998617731518 · Cited by 16
Preventive Dental Care and Long‐Term Dental Outcomes among ALL Kids Enrollees
Sen, B., Blackburn, J. L., Kilgore, M. L., Morrisey, M. A., Becker, D. J., Caldwell, C., & Menachemi, N. (2016) · Health Services Research · doi:10.1111/1475-6773.12469 · Cited by 14
Use of Lipid‐Lowering Drugs and the Risk of Cataract: A Population‐Based Nested Case‐Control Study
Bezin, J., Mansiaux, Y., Noïze, P., Salvo, F., Bégaud, B., & Pariente, A. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1176 · Cited by 14
Lai, E. C., Shin, J., Kubota, K., Man, K. K. C., Park, B., Pratt, N. L., Roughead, E. E., Wong, I. C. K., Yang, Y. K., & Setoguchi, S. (2018) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4663 · Cited by 14
Sequential Monitoring of the Comparative Effectiveness and Safety of Dabigatran in Routine Care
Schneeweiß, S., Gopalakrishnan, C., Bartels, D. B., Franklin, J. M., Zint, K., Kulldorff, M., & Huybrechts, K. F. (2019) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.118.005173 · Cited by 14
Change in healthcare during Covid-19 pandemic was assessed through observational designs
Corrao, G., Cantarutti, A., Compagnoni, M. M., Franchi, M., & Rea, F. (2021) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2021.10.015 · Cited by 16
Gruber, S., & van der Laan, M. J. (2012) · Statistical Methods in Medical Research · doi:10.1177/0962280212437451 · Cited by 14
Rassen, J. A., & Schneeweiß, S. (2012) · Journal of Comparative Effectiveness Research · doi:10.2217/cer.12.12 · Cited by 14
Self-citationComparative safety of antimuscarinics versus mirabegron for overactive bladder in Parkinson disease
Abraham, D. S., Nguyen, T. P. P., Newcomb, C. W., Gray, S. L., Hennessy, S., Leonard, C. E., Liu, Q., Weintraub, D. A., & Willis, A. W. (2023) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2023.105822 · Cited by 13
Blin, P., Dureau‐Pournin, C., Bénichou, J., Bonello, L., Dallongeville, J., Danchin, N., Falissard, B., Thomas‐Delecourt, F., Jové, J., Lassalle, R., et al. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.11.037 · Cited by 13
Active Vaccine Safety Surveillance: Global Trends and Challenges in China
Liu, Z., Meng, R., Yang, Y., Li, K., Yin, Z., Ren, J., Shen, C., Feng, Z., & Zhan, S. (2021) · Health Data Science · doi:10.34133/2021/9851067 · Cited by 14
How Did the COVID-19 Crisis Affect Different Types of Workers in the Developing World?
Kugler, M. D., Viollaz, M., Duque, D., Gaddis, I., Newhouse, D., Palacios-López, A., & Weber, M. (2021) · World Bank, Washington, DC eBooks · doi:10.1596/35950 · Cited by 13
Integrating Nearest Neighbors with Neural Network Models for Treatment Effect Estimation
Kiriakidou, N., & Diou, C. (2023) · International Journal of Neural Systems · doi:10.1142/s0129065723500363 · Cited by 13
The missing cause approach to unmeasured confounding in pharmacoepidemiology
Abrahamowicz, M., Bjerre, L. M., Beauchamp, M., LeLorier, J., & Burne, R. M. (2016) · Statistics in Medicine · doi:10.1002/sim.6818 · Cited by 13
Cholinesterase Inhibitor Utilization: The Impact of Provincial Drug Policy on Discontinuation
Fisher, A., Carney, G., Bassett, K. L., & Chappell, N. L. (2016) · Value in Health · doi:10.1016/j.jval.2016.03.1832 · Cited by 13
Comparative persistence of antiepileptic drugs in patients with epilepsy
Lai, E. C., Hsieh, C., Su, C., Yang, Y. K., Huang, C., Lin, S., & Setoguchi, S. (2016) · Medicine · doi:10.1097/md.0000000000004481 · Cited by 13
Homayra, F., Hongdilokkul, N., Piske, M., Pearce, L. A., Zhou, H., Min, J. E., Krebs, E., & Nosyk, B. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.107798 · Cited by 13
Comparative effectiveness of dimethyl fumarate in multiple sclerosis
Bosco‐Lévy, P., Debouverie, M., Brochet, B., Guillemin, F., Louapre, C., Maillart, É., Heinzlef, O., Lignot, S., Diez, P., Abouelfath, A., et al. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15071 · Cited by 13
Exhaustion, Automation, Theory, and Confounding
Joffe, M. M. (2009) · Epidemiology · doi:10.1097/ede.0b013e3181a82501 · Cited by 13
Afferent loop obstruction after gastrectomy simulating acute pancreatitis.
Alawneh, I. (1980) · PubMed · Cited by 13
Sato, S., Sasabuchi, Y., Okada, A., & Yasunaga, H. (2025) · Dysphagia · doi:10.1007/s00455-024-10737-8 · Cited by 12
Desai, R. J., Bradley, M. C., Lee, H., Eworuke, E., Weberpals, J. G., Wyss, R., Schneeweiß, S., & Ball, R. (2024) · American Journal of Epidemiology · doi:10.1093/aje/kwae102 · Cited by 12
Hyperkalemia and Risk of CKD Progression: A Propensity Score–Matched Analysis
Agiro, A., Cook, E. E., Mu, F., Greatsinger, A., Chen, J., Zhao, A., Louden, E. M., Colman, E., Desai, P., & Chertow, G. M. (2024) · Kidney360 · doi:10.34067/kid.0000000000000541 · Cited by 12
Kesselheim, A. S., & Avorn, J. (2012) · Health Affairs · doi:10.1377/hlthaff.2012.0787 · Cited by 12
Self-citationWong, M. C. S., Tam, W., Wang, H., Cheung, C. S. K., Tong, E. L. H., Sek, A. C. H., Cheung, N. T., Yan, B. P.-Y., Yu, C., Leeder, S., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.07.174 · Cited by 12
Clinical Diabetes Research Using Data Mining: A Canadian Perspective
Shah, B. R., & Lipscombe, L. L. (2015) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2015.02.005 · Cited by 12
Douros, A., Dell’Aniello, S., Yu, O. H. Y., & Suissa, S. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13893 · Cited by 12
Saliba, W., Arbel, A., Abu‐Ful, Z., Cohen, S., Rennert, G., & Preis, M. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.03.002 · Cited by 12
Metadata
- Authors
- Schneeweiss, S., Rassen, J. A., Glynn, R. J., Avorn, J., Mogun, H., & Brookhart, M. A.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Schneeweiss, Sebastian
- Venue
- Epidemiology
- Published
- 2009-07
- Volume
- 20
- Issue
- 4
- Pages
- 512-522
- ISSN
- 1044-3983 (ISSN-L)
- PMC
- PMC3077219
- OpenAlex
- W1967862917
- Cited by
- 1,128
- References
- 44
- Citations by year
- 2026: 51 · 2025: 78 · 2024: 77 · 2023: 62 · 2022: 71 · 2021: 104 · 2020: 87 · 2019: 86 · 2018: 69 · 2017: 73 · 2016: 72 · 2015: 62 · 2014: 61 · 2013: 66 · 2012: 55
- FWCI
- 29.60
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (1r01lm010213-01)
- National Institute on Aging (R01AG021950, R01-AG027400, K25AG027400, R01AG018833, R01AG023178)
- National Institute of Mental Health (R01-MH078708, U01MH078708)
- U.S. National Library of Medicine (R01-LM010213)
- Topics
- Physical Sciences › Mathematics › Statistics and Probability › Advanced Causal Inference Techniques
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Epidemiology
- Health Sciences › Health Professions › Health Information Management › Medical Coding and Health Information
- Keywords
- high-dimensional propensity score, confounding adjustment, health insurance claims, COX-2 inhibitors, non-selective NSAIDs, influenza vaccination, hip fracture, Medicare claims data, pharmacoepidemiology
- MeSH terms
- Aged, Aged, 80 and over, Algorithms, Anti-Inflammatory Agents, Non-Steroidal, Female, Medicare, Humans, Insurance Claim Review, Male, United States, Confounding Factors, Epidemiologic, Treatment Outcome, Pharmacoepidemiology, Risk Assessment, Upper Gastrointestinal Tract, Cyclooxygenase 2 Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review